Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab | 540788
Share Price Chart - Aspira Pathlab & Diagnostics Ltd
Stock Performance
Ratios
About Company
- Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973
- ASDL is a leading pathology specialist, with Pan-India presence
- It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses
- The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services
- Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers
- Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai
- ASDL ideology is founded on technological supremacy, patient centric approach, and dependable diagnostic results
- During the year 2016, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of 'Ankur Pathology Laboratory'
- Aspira is focused on establishing itself as a strong regional player before scaling up its operations
- Although, it follow an asset light model, other costs are significantly high
Research Calls
Technical Indicators
Pivot Points
No Information Available
Volume Analysis data is not available at this time.
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Aspira Pathlab & Diagnostics Ltd?
The current share price of Aspira Pathlab & Diagnostics Ltd (Aspira Pathlab) is ₹99.85. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Aspira Pathlab & Diagnostics Ltd?
The Price-to-Earnings (P/E) ratio of Aspira Pathlab & Diagnostics Ltd is 99.85. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Aspira Pathlab & Diagnostics Ltd?
Aspira Pathlab & Diagnostics Ltd has a 52-week high of ₹135.88 and a 52-week low of ₹49.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Aspira Pathlab & Diagnostics Ltd?
Aspira Pathlab & Diagnostics Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Aspira Pathlab & Diagnostics Ltd?
The Earnings Per Share (EPS) of Aspira Pathlab & Diagnostics Ltd is ₹2.33. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Aspira Pathlab & Diagnostics Ltd?
Aspira Pathlab & Diagnostics Ltd has a Return on Equity (ROE) of 16.88%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
